Opinion

Video

Novel Treatment and Diagnostics for Dry Eye

Author(s):

Laura Periman, MD,Kelly Nichols, OD

Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.

0:55 Treatment Advanced

5:00 Treating Demodex

13:40 Semifluorinated Alkanes

16:15 Treatment Selection

22:10 New Research Targets

28:50 AI in Diagnostics

Related Videos
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Related Content
ONS-5010 for Wet AMD Secures Noninferiority in NORSE EIGHT Trial | Image Credit: Wills Eye Hospital
January 19th 2025

ONS-5010 for Wet AMD Secures Noninferiority in NORSE EIGHT Trial

Connor Iapoce
New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD | Image Credit: HCPLive
September 5th 2024

New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD

Connor Iapoce
SING IMT Device Secures Positive 6-Month Data for Late-Stage AMD | Image Credit: LinkedIn
January 14th 2025

SING IMT Device Secures Positive 6-Month Data for Late-Stage AMD

Connor Iapoce
MEDcast logo
August 1st 2024

Optimizing Treatment Outcomes in Retinal Vein Occlusion

Hong-Uyen Hua, MD Sruthi Arepalli, MD Geeta Lalwani, MD
4D-150 Reduces Injection Burden in DME, Paving Way for FDA-Backed Phase 3| Image Credit: LinkedIn
January 10th 2025

4D-150 Reduces Injection Burden in DME, Paving Way for FDA-Backed Phase 3

Connor Iapoce
Credit: Adobe Stock/ Africa Studio
January 9th 2025

Retinal Alterations Reveal Insights Into Schizophrenia, Sclerosis Risk

Chelsie Derman
© 2025 MJH Life Sciences

All rights reserved.